4.8 Review

Regulated necrosis: disease relevance and therapeutic opportunities

期刊

NATURE REVIEWS DRUG DISCOVERY
卷 15, 期 5, 页码 348-366

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrd.2015.6

关键词

-

资金

  1. Deutsche Forschungsgemeinschaft (DFG) [CO 291/2-3]
  2. DFG Priority Programme 1710 [CO 291/5-1]
  3. Human Frontier Science Program (HFSP) [RGP0013/14]
  4. m4 Award (Bavarian Ministry of Economic Affairs)
  5. New York State Stem Cell Science (NYSTEM) [C026715]
  6. US National Institutes of Health (NIH) [5R01CA097061, 1R21CA177591, R01CA161061]
  7. US National Science Foundation [CHE 0840451]
  8. NIH [1S10RR025431-01A1]
  9. Belgian grants (Interuniversity Attraction Poles) [IAP 7/32]
  10. Flemish grants (Research Foundation Flanders) [FWOG.0875.11, FWO G.0973.11N, FWO G.0A45.12N, FWO G.0172.12, FWO G.0787.13N, G0C3114N, FWO KAN 31528711]
  11. Flemish grants (Foundation against Cancer) [2012-188]
  12. Ghent University grants (MRP, GROUP-ID consortium)
  13. Flanders Institute for Biotechnology
  14. Flemish Government [BOF09/01M00709]

向作者/读者索取更多资源

The discovery of regulated cell death presents tantalizing possibilities for gaining control over the life-death decisions made by cells in disease. Although apoptosis has been the focus of drug discovery for many years, recent research has identified regulatory mechanisms and signalling pathways for previously unrecognized, regulated necrotic cell death routines. Distinct critical nodes have been characterized for some of these alternative cell death routines, whereas other cell death routines are just beginning to be unravelled. In this Review, we describe forms of regulated necrotic cell death, including necroptosis, the emerging cell death modality of ferroptosis (and the related oxytosis) and the less well comprehended parthanatos and cyclophilin D-mediated necrosis. We focus on small molecules, proteins and pathways that can induce and inhibit these non-apoptotic forms of cell death, and discuss strategies for translating this understanding into new therapeutics for certain disease contexts.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据